Market Research Industry Reports

Drugs for Neglected Diseases initiative - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Drugs for Neglected Diseases initiative - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Drugs for Neglected Diseases initiative Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Drugs for Neglected Diseases initiative since January2007.

Synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Hightlights

- This report includes Drugs for Neglected Diseases initiatives contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
- The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Drugs for Neglected Diseases initiative. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Drugs for Neglected Diseases initiatives M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Drugs for Neglected Diseases initiative and its subsidiaries since 2007.
- Information about key financial and legal advisors for Drugs for Neglected Diseases initiatives financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Drugs for Neglected Diseases initiatives growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.

COMPANY OVERVIEW AND KEY FACTS 2

TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership - Overview 7
Partnership - Deal reports 8
APPENDIX 106
Contact Us 106
About MarketLine Financial Deals Database 106
Deal Definition and Methodology 108
About MarketLine 115

List Of Tables

List of Tables
Table 1: Drugs for Neglected Diseases initiative partnership volume and value trend (2014-YTD2018)
Table 2: Drugs for Neglected Diseases initiative partnership trend by key deal type (2014-YTD2018)

List Of Figures

List of Figures
Figure 1: Drugs for Neglected Diseases initiative partnership volume and value trend (2014-YTD2018)
Figure 2: Drugs for Neglected Diseases initiative partnership trend by key deal type (2014-YTD2018)

2018 US Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

This new 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading

USD 3500View Report

2018 UK Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

This new 260-page report provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading

USD 2450View Report

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Professional Survey Report 2018

This report studies Drugs for Vancomycin-Resistant Enterococcus Faecium in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in

USD 3500View Report

Global Drugs for Mouth Ulcer Market Size, Status and Forecast 2025

This report studies the global Drugs for Mouth Ulcer market, analyzes and researches the Drugs for Mouth Ulcer development status and forecast in United States, EU, Japan, China, India and

USD 3300View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 350
  • Site Licence    USD 700
  • Enterprise Wide Licence    USD 1050
$ 350

Reports Details

Published Date : Mar 2018
No. of Pages :116
Country :Switzerland
Category :Pharmaceuticals and Healthcare
Publisher :MarketLine
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube